 DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, AND FILGRASTIM FOLLOWED BY PACLITAXEL ALBUMIN-STABILIZED NANOPARTICLE FORMULATION WITH OR WITHOUT TRASTUZUMAB IN TREATING PATIENTS WITH BREAST CANCER PREVIOUSLY TREATED WITH SURGERY: 